Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Pediatr Infect Dis J. 2017 Nov;36(11):e258–e263. doi: 10.1097/INF.0000000000001575

Table 2.

Unadjusted associations between baseline characteristics and virologic failure or death1 at 6-months

Virologic failure2 (n=43) No virologic failure (n=77) p-value
N (%) N (%)
Age (years), median (IQR) 2.4 (1.5–5.2) 2.8 (1.6–5.0) 0.58
Female 16 (37%) 32 (42%) 0.70
Baseline WHO stage 3 or 4 38 (88%) 65 (84%) 0.79
Antenatal PMTCT exposure 3 (7%) 0 (0%) 0.79
Maternal ARV postdelivery 10 (23%) 6 (8%) 0.04
Any breastfeeding3 40 (93%) 69 (90%) 0.74
Poor adherence 16 (37%) 9 (12%) 0.002
Baseline NNRTI-resistance 18 (42%) 9 (12%) <0.001
ART regimen initiated on study
 NNRTI-based 23 (53%) 49 (64%) 0.33
 PI-based 20 (47%) 28 (36%) 0.33
1

Death occurring at least 1 month after ART initiation

2

Also includes 4 deaths occurring at least 1 month after ART initiation.

3

Includes exclusive and mixed breastfeeding.